Supplement
Phosphatidylserine is a fat-like phospholipid that sits in the membranes of brain cells, where it helps nerve cells signal to one another. People mostly look at it for memory problems such as mild cognitive impairment, and small trials found cognition and forgetting improved, though the evidence is limited. Those studies were tiny, with 8 to 18 people each, and one tested it alongside omega-3 fats, so the findings are early.
Sources: PMID 20523044
- Updated
- How we grade
- 12 studies cited
- Best evidence
- Grade B
- Conditions studied
- 16
- Outcomes
- 73
- Graded outcomes
- 01105
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
Alzheimer’s Disease
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cognitive Decline Small Improvement | Improves (the measure goes down) | Small effect | 2 studies | 92 people | ||
| Cerebral Glucose Utilization Small Increase | Changes; see studies | Small effect | 8 people | |||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cognition Small Improvement | Improves (the measure goes up) | Small effect | 1 study | 18 people | ||
| Cortisol | Improves (the measure goes down) | 1 study | 18 people | |||
Studies that measured cortisol | ||||||
| Fatigue Symptoms | Improves (the measure goes down) | 1 study | 18 people | |||
Studies that measured fatigue symptoms | ||||||
| Stress Signs and Symptoms | Improves (the measure goes down) | 1 study | 16 people | |||
Studies that measured stress signs and symptoms | ||||||
| Processing Accuracy | Improves (the measure goes up) | 18 people | ||||
| Processing Speed | Improves (the measure goes up) | 18 people | ||||
| Subjective Well-Being | Improves (the measure goes up) | 18 people | ||||
| Testosterone | Improves (the measure goes up) | 18 people | ||||
Memory Improvement
- Cognition: improves
- Memory: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cognition Small Improvement | Improves (the measure goes up) | Small effect | 1 study | 122 people | ||
| Memory | Improves (the measure goes up) | 1 study | 122 people | |||
Studies that measured memory | ||||||
Metabolic Health
- Cognition: improves
- Cortisol: improves
- Fatigue Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cognition Small Improvement | Improves (the measure goes up) | Small effect | 1 study | 18 people | ||
| Cortisol | Improves (the measure goes down) | 1 study | 18 people | |||
Studies that measured cortisol | ||||||
| Fatigue Symptoms | Improves (the measure goes down) | 1 study | 18 people | |||
Studies that measured fatigue symptoms | ||||||
| Processing Accuracy | Improves (the measure goes up) | 18 people | ||||
| Testosterone | Improves (the measure goes up) | 18 people | ||||
Mood Improvement
- Cognition: improves
- Cortisol: improves
- Fatigue Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cognition Small Improvement | Improves (the measure goes up) | Small effect | 1 study | 18 people | ||
| Cortisol | Improves (the measure goes down) | 1 study | 18 people | |||
Studies that measured cortisol | ||||||
| Fatigue Symptoms | Improves (the measure goes down) | 1 study | 18 people | |||
Studies that measured fatigue symptoms | ||||||
| Processing Accuracy | Improves (the measure goes up) | 18 people | ||||
| Processing Speed | Improves (the measure goes up) | 18 people | ||||
| Subjective Well-Being | Improves (the measure goes up) | 18 people | ||||
| Testosterone | Improves (the measure goes up) | 18 people | ||||
Attention Deficit Hyperactivity Disorder (ADHD)
- ADHD Symptoms: improves
- Attention: improves
- Hyperactivity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| ADHD Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 216 people | |||
| Attention | Improves (the measure goes up) | 1 study | 216 people | |||
| Hyperactivity | Improves (the measure goes up) | 216 people | ||||
| Impulsivity | Improves (the measure goes up) | 216 people | ||||
Cycling Performance
- Anaerobic Capacity: improves
- Cortisol: improves
- Fatigue Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anaerobic Capacity Moderate Improvement | Improves (the measure goes up) | Moderate effect | 14 people | |||
| Cortisol | Improves (the measure goes down) | 1 study | 14 people | |||
Studies that measured cortisol | ||||||
| Fatigue Symptoms | Improves (the measure goes down) | 1 study | 14 people | |||
Studies that measured fatigue symptoms | ||||||
| Fat Oxidation | Improves (the measure goes up) | 14 people | ||||
| Oxygen Cost of Exercise | Improves (the measure goes up) | 14 people | ||||
Golf Performance
- Golf Performance Metrics: improves
- Stress Signs and Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Golf Performance Metrics Small Improvement | Improves (the measure goes up) | Small effect | 20 people | |||
| Stress Signs and Symptoms | Improves (the measure goes down) | 1 study | 20 people | |||
Studies that measured stress signs and symptoms | ||||||
Mild Cognitive Impairment (MCI)
- Forgetting: improves
- Memory: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Forgetting Small Improvement | Improves (the measure goes up) | Small effect | 15 people | |||
| Memory | Improves (the measure goes up) | 1 study | 15 people | |||
Studies that measured memory | ||||||
Alzheimer’s Disease
- Cerebral Glucose Utilization: changes; see studies
- Cognitive Decline: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cerebral Glucose Utilization Small Increase | Changes; see studies | Small effect | 8 people | |||
| Cognitive Decline | Changes; see studies | 2 studies | 92 people | |||
Mental Resilience
- Heart Rate
- Stress Signs and Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Heart Rate No effect | NoneNo effect | 1 study | 16 people | |||
Studies that measured heart rate | ||||||
| Stress Signs and Symptoms | Improves (the measure goes down) | 1 study | 16 people | |||
Studies that measured stress signs and symptoms | ||||||
Running Performance
- Cortisol
- Exercise-Induced Oxidation: changes; see studies
- Inflammation: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cortisol No effect | NoneNo effect | 1 study | 8 people | |||
Studies that measured cortisol | ||||||
| Exercise-Induced Oxidation | Changes; see studies | 1 study | 8 people | |||
Studies that measured exercise-induced oxidation | ||||||
| Inflammation | Improves (the measure goes down) | 8 people | ||||
| Muscle Damage | Changes; see studies | 8 people | ||||
| Muscle Soreness | Improves (the measure goes down) | 8 people | ||||
Stress
- Blood Lactate (Exercise)
- Cortisol: improves
- Growth Hormone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Lactate (Exercise) No effect | NoneNo effect | 1 study | 9 people | |||
| Cortisol | Improves (the measure goes down) | 1 study | 9 people | |||
| Growth Hormone | Improves (the measure goes up) | 9 people | ||||
| Prolactin | Improves (the measure goes up) | 9 people |
Age Associated Memory Impairment And Cognitive Decline Aamcd
- Blood Pressure
- Cognitive Decline: improves
- Cognition: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure No effect | NoneNo effect | 78 people | ||||
| Cognitive Decline | Improves (the measure goes down) | 2 studies | 198 people | |||
| Cognition | Improves (the measure goes up) | 1 study | 200 people | |||
| Heart Rate | Improves (the measure goes down) | 1 study | 78 people | |||
| Memory | Improves (the measure goes up) | 1 study | 242 people | |||
| Reaction Time | Improves (the measure goes up) | 1 study | 120 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 78 people | ||||
| Liver Enzymes | Changes; see studies | 78 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 78 people | ||||
| Total cholesterol | Improves (the measure goes down) | 78 people | ||||
| Triglycerides | Improves (the measure goes down) | 78 people |
Age-Associated Memory Impairment and Cognitive Decline (AAMCD)
- Blood Pressure
- Cognitive Decline: changes; see studies
- Cognition: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure No effect | NoneNo effect | 78 people | ||||
| Cognitive Decline | Changes; see studies | 2 studies | 198 people | |||
| Cognition | Improves (the measure goes up) | 1 study | 200 people | |||
| Heart Rate | Changes; see studies | 1 study | 78 people | |||
| Memory | Improves (the measure goes up) | 1 study | 242 people | |||
| Reaction Time | Improves (the measure goes up) | 1 study | 120 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 78 people | ||||
| Liver Enzymes | Changes; see studies | 78 people | ||||
| Low-density lipoprotein (LDL) | Changes; see studies | 78 people | ||||
| Total cholesterol | Changes; see studies | 78 people | ||||
| Triglycerides | Changes; see studies | 78 people |
Dementia
- Cognitive Decline: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cognitive Decline | Improves (the measure goes down) | 2 studies | 33 people |
What the published studies found
1 automated reading
Cognitive function
The best available review (2026, 11 studies) found little or no difference in cognitive function. That review studied children, adolescents, and adults with mental disorders. 3 of the 6 studies read agree; 3 found an improvement. The evidence is moderate.
6 studies counted of 9 read: 1 review and 5 trials (710 people in the trials).
- Systematic review, 2026; 11 studies; children, adolescents, and adults with mental disorders: no clear difference (the review the verdict rests on).
findings were heterogeneous and inconsistent across diagnostic groups
The Impact of Citicoline/Phosphatidylserine Supplementation on Cognitive Performance and Executive Functions in Mental Disorders: A Systematic Review of Controlled Trials - Crossover trial, 2013; recreationally trained individuals: no clear difference.
does not affect CF or RT
Phosphatidylserine and caffeine attenuate postexercise mood disturbance and perception of fatigue in humans - Crossover trial, 2011; 18 people; lower body resistance trained college aged males: improves.
significantly reduced the time needed for a correct calculation
The effects of IQPLUS Focus on cognitive function, mood and endocrine response before and following acute exercise - Randomised trial, 2010; 78 people: improves.
memory scores in PS treated groups were significantly increased
Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints - Randomised trial, 2001; 120 people: no clear difference.
No significant differences were found in any of the outcome variables
The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment - Randomised trial, 1993; 494 people; elderly patients with moderate to severe cognitive decline: improves.
Statistically significant improvements in the phosphatidylserine-treated group
Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration
- Systematic review, 2026; 11 studies; children, adolescents, and adults with mental disorders: no clear difference (the review the verdict rests on).
Key findings
- Cognitive DeclineImproves (the measure goes down)
- CognitionImproves (the measure goes up)
- Cerebral Glucose UtilizationChanges; see studies
Shop the evidence-backed picks
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
Third-party tested Phosphatidylserine products, in the forms the graded studies used where we can match them.
- Grade B
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
12 studies from PubMed
- The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment
- Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints
- Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial
- Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type
- Effects of phosphatidylserine in Alzheimer's disease
- The effects of IQPLUS Focus on cognitive function, mood and endocrine response before and following acute exercise
- Influence of phosphatidylserine on cognitive performance and cortical activity after induced stress
- Phosphatidylserine supplementation and recovery following downhill running
- An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive decline
- Effects of phosphatidylserine on exercise capacity during cycling in active males
- Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men
- Phosphatidylserine for the Treatment of Pediatric Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis